2004Book or chapter
Neil Shear, Jerome Z. Litt
CRC Press eBooks
Death (2003): Edwards IR, Lancet 361, 1240 (11 cases) Dysgeusia (2%) Foetor ex ore (halitosis) (<1%) Gingivitis (<1%) Glossitis (<1%) Gynecomastia (<1%) Headache Hyperesthesia (<1%) Mastodynia (1%) Myalgia Oral candidiasis (<1%) Oral ulceration (<1%) Paresthesias (4%) (1999): Litt JZ, Beachwood, OH (personal case) (observation) Priapism (<1%) (1999): Brodie-Meijer CC+, Int Clin Psychopharmacol 14, 257 (clitoral) Rhabdomyolysis (2002): Thompson M+, Am J Psychiatry 159(9), 1607 (with simvastatin) Sialorrhea (<1%) Stomatitis (<1%) Vaginitis (2%) Xerostomia (25%) Trade name: Viracept (Pfizer) Indications: HIV infection Category: Antiretroviral; Protease inhibitor Half-life: 3.5-5 hours Clinically important, potentially hazardous interactions with: benzodiazepines, chlordiazepoxide, clonazepam, clorazepate, diazepam, dihydroergotamine, ergot alkaloids, fentanyl, flurazepam, lorazepam, methysergide, midazolam, oral contraceptives, oxazepam, phenytoin, pimozide, quazepam, rifampin, sildenafil, St John’s wort, temazepam Reactions Skin Allergic reactions (sic) (<1%) Dermatitis (sic) (<1%) Diaphoresis (<1%) Exanthems (1998): Bourezane Y+, Clin Infect Dis 27(5), 1321 (with indinavir) Hyperhidrosis (2000): Bonfanti P+, J Acquir Immune Defic Syndr 23(3), 236 Lichenoid eruption (1998): Bourezane Y+, Clin Infect Dis 27(5), 1321 Palmar erythema (1998): Bourezane Y+, Clin Infect Dis 27(5), 1321 (with indinavir) Pruritus (<1%) Rash (sic) (1-10%) (2001): Abraham PE+, Ann Pharmacother 35(5), 553 (2000): Fortuny C+, AIDS 14, 335 Urticaria (<1%) (1998): Demoly P+, J Allergy Clin Immunol 102(5), 875 Vasculitis (1998): Bourezane Y+, Clin Infect Dis 27(5), 1321 Other DRESS syndrome (1998): Bourezane Y+, Clin Infect Dis 27, 1321 Gynecomastia (2001): Manfredi R+, Ann Pharmacother 35(4), 438…
Abstract shortened. Read the full abstract at the source.
Abstract text comes from PubMed, OpenAlex or Europe PMC and belongs to the authors and publisher.
Study type
Other / not stated
Assigned automatically from the title, abstract and subject terms.
Topics
Matcha is mentioned in passing here (named in the abstract).
Neil Shear, Jerome Z. Litt. (2004). NEFAZODONE. CRC Press eBooks. https://doi.org/10.3109/9780203492079-125
DOI: 10.3109/9780203492079-125
Japanese matcha is a type of powdered green tea, grown in a traditional way. Shading of the plants during the growth period enhances the processes of synthesis and accumulation of biologically active compounds, including theanine,…
ReviewCognition, mood and stressAntioxidants and polyphenolsL-theanine and caffeineCited 321×We investigated the anticarcinogenic potential of green tea and its components epigallocatechin gallate (EGCG) and quercetin, as well as tamoxifen, on MCF-7 and MDA-MB-23 breast cancer cells. Using high-performance liquid chromatography,…
In vitro / cell studyAntioxidants and polyphenolsCancerInflammation and immunityCited 76×Lately, matcha green tea has gained popularity as a beverage and food additive. It has proved to be effective in preventing obesity and related metabolic syndromes. However, the underlying mechanisms of its control effects against…
Animal studyMetabolism and weightInflammation and immunityAntioxidants and polyphenolsCited 48×This study was conducted to evaluate the anti-amnesic effect of the aqueous extract of powdered green tea (matcha) (EM) in particulate matter (PM)2.5-induced systemic inflammation in BALB/c mice. EM ameliorated spatial learning and memory…
Animal studyCognition, mood and stressAntioxidants and polyphenolsCancerCited 34×